XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Financial Instruments And Risk Management | 9 Months Ended
--- | ---
Sep. 30, 2018
Derivative Instruments and Hedges, Assets [Abstract] |
Financial Instruments And Risk Management | FINANCIAL INSTRUMENTS AND RISK MANAGEMENT In the normal course of business, the Company's financial position, results of operations and cash flows are routinely subject to a variety of risks. These risks include risks associated with financial markets, primarily currency exchange rate risk and, to a lesser extent, interest rate risk and equity market risk. The Company regularly assesses these risks and has established policies and business practices designed to mitigate them. The Company does not engage in speculative trading in any financial market. The Company actively manages the risk of changes in functional currency equivalent cash flows resulting from anticipated non-functional currency denominated purchases and sales. Subsidiaries that use European euros, Canadian dollars, Japanese yen, Chinese renminbi, or Korean won as their functional currency are primarily exposed to changes in functional currency equivalent cash flows from anticipated U.S. dollar inventory purchases. The Company's prAna subsidiary uses U.S. dollars as its functional currency and is exposed to anticipated Canadian dollar denominated sales. The Company manages these risks by using currency forward and option contracts formally designated and effective as cash flow hedges. Hedge effectiveness is generally determined by evaluating the ability of a hedging instrument's cumulative change in fair value to offset the cumulative change in the present value of expected cash flows on the underlying exposures. For forward contracts, forward points are excluded from the determination of hedge effectiveness and are included in current period cost of sales for hedges of anticipated U.S. dollar inventory purchases and in net sales for hedges of anticipated Canadian dollar sales on a straight-line basis over the life of the contract. In each accounting period, any difference between the change in fair value of the forward points and the amount recognized in earnings on a straight-line basis is recognized in Other comprehensive income in the Condensed Consolidated Statements of Comprehensive Income. For option contracts, the change in fair value attributable to changes in time value are excluded from the assessment of hedge effectiveness and included in current period Cost of sales in the Condensed Consolidated Statements of Operations. Hedge ineffectiveness was not material during the three and nine months ended September 30, 2018 and 2017. The Company also uses currency forward contracts not formally designated as hedges to manage the consolidated currency exchange rate risk associated with the remeasurement of non-functional currency denominated monetary assets and liabilities by subsidiaries that use U.S. dollars, euros, Canadian dollars, yen, won, or renminbi as their functional currency. Non-functional currency denominated monetary assets and liabilities consist primarily of cash and cash equivalents, short-term investments, receivables, payables, deferred income taxes, and intercompany loans. The gains and losses generated on these currency forward contracts not formally designated as hedges are expected to be largely offset in other non-operating expense, net by the gains and losses generated from the remeasurement of the non-functional currency denominated monetary assets and liabilities. The following table presents the gross notional amount of outstanding derivative instruments (in thousands):
| September 30, 2018 |  | December 31, 2017 |  | September 30, 2017
Derivative instruments designated as cash flow hedges: |  |  |  |  |
Currency forward contracts | $ | 434,738 |  |  | $ | 448,448 |  |  | $ | 390,500 |
Derivative instruments not designated as cash flow hedges: |  |  |  |  |
Currency forward contracts | 289,772 |  |  | 231,161 |  |  | 181,045 |
At September 30, 2018, approximately $3,247,000 of deferred net gains on both outstanding and matured derivatives accumulated in Other comprehensive income are expected to be reclassified to net income during the next twelve months as a result of underlying hedged transactions also being recorded in net income. Actual amounts ultimately reclassified to Net income in the Condensed Consolidated Statements of Comprehensive Income are dependent on U.S. dollar exchange rates in effect against the euro, renminbi, Canadian dollar, and yen when outstanding derivative contracts mature. At September 30, 2018, the Company's derivative contracts had a remaining maturity of less than three years. The maximum net exposure to any single counterparty, which is generally limited to the aggregate unrealized gain of all contracts with that counterparty, was less than $5,000,000 at September 30, 2018. All of the Company's derivative counterparties have investment grade credit ratings. The Company is a party to master netting arrangements that contain features that allow counterparties to net settle amounts arising from multiple separate derivative transactions or net settle in the case of certain triggering events such as a bankruptcy or major default of one of the counterparties to the transaction. The Company has not pledged assets or posted collateral as a requirement for entering into or maintaining derivative positions. The following table presents the balance sheet classification and fair value of derivative instruments (in thousands):
|  | Balance Sheet Classification |  | September 30, 2018 |  | December 31, 2017 |  | September 30, 2017
Derivative instruments designated as cash flow hedges: |  |  |  |  |  |  |  |
Derivative instruments in asset positions: |  |  |  |  |  |  |  |
Currency forward contracts |  | Prepaid expenses and other current assets |  | $ | 7,262 |  |  | $ | 1,648 |  |  | $ | 1,930 |
Currency forward contracts |  | Other non-current assets |  | 7,963 |  |  | 335 |  |  | 509 |
Derivative instruments in liability positions: |  |  |  |  |  |  |  |
Currency forward contracts |  | Accrued liabilities |  | 584 |  |  | 9,336 |  |  | 10,152 |
Currency forward contracts |  | Other long-term liabilities |  | — |  |  | 3,820 |  |  | 3,048 |
Derivative instruments not designated as cash flow hedges: |  |  |  |  |  |  |  |
Derivative instruments in asset positions: |  |  |  |  |  |  |  |
Currency forward contracts |  | Prepaid expenses and other current assets |  | 865 |  |  | 683 |  |  | 959 |
Derivative instruments in liability positions: |  |  |  |  |  |  |  |
Currency forward contracts |  | Accrued liabilities |  | 154 |  |  | 1,229 |  |  | 407 |
The following table presents the statement of operations effect and classification of derivative instruments (in thousands):
| Statement of Operations Classification |  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2018 |  | 2017 |  | 2018 |  | 2017
Currency Forward and Option Contracts: |  |  |  |  |  |  |  |  |
Derivative instruments designated as cash flow hedges: |  |  |  |  |  |  |  |
Gain (loss) recognized in other comprehensive income or loss, net of tax | — |  | $ | 866 |  |  | $ | (7,535 | ) |  | $ | 16,493 |  |  | $ | (14,510 | )
Gain reclassified from accumulated other comprehensive income or loss to income for the effective portion | Net sales |  | 17 |  |  | — |  |  | 41 |  |  | 144 |
(Loss) gain reclassified from accumulated other comprehensive income or loss to income for the effective portion | Cost of sales |  | (4,192 | ) |  | 1,549 |  |  | (7,796 | ) |  | 2,500 |
Loss reclassified from accumulated other comprehensive income or loss to income as a result of cash flow hedge discontinuance | Other non-operating expense |  | — |  |  | (178 | ) |  | — |  |  | (178 | )
Gain recognized in income for amount excluded from effectiveness testing and for the ineffective portion | Net sales |  | 4 |  |  | — |  |  | 16 |  |  | 5 |
Gain recognized in income for amount excluded from effectiveness testing and for the ineffective portion | Cost of sales |  | 1,637 |  |  | 1,203 |  |  | 5,458 |  |  | 2,489 |
Derivative instruments not designated as cash flow hedges: |  |  |  |  |  |  |  |
Gain (loss) recognized in income | Other non-operating expense |  | 372 |  |  | (634 | ) |  | 2,606 |  |  | (4,045 | )

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI http://asc.fasb.org/topic&trid=2229140 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration